Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Den Broek Richard Van currently holds 20,000 shares of PhaseBio Pharmaceuticals Inc (PHAS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Den Broek Richard Van has been a net seller of PHAS stock. They have purchased $168.6K and sold $13.9M worth of shares.
Den Broek Richard Van's most recent insider trade was on Jun 6, 2024, when they sold 20,000 shares at $0.00 per share.
Den Broek Richard Van serves as Executive at PhaseBio Pharmaceuticals Inc (PHAS). They have executed 26 insider transactions totaling $14.1M over their tenure at the company.
Den Broek Richard Van holds the position of Executive at PhaseBio Pharmaceuticals Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Den Broek Richard Van has shown a selling trading pattern, with $168.6K in total purchases and $13.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Den Broek Richard Van was on May 26, 2015, when they sold $7.7M worth of PCYC shares. This transaction involved 29,610 shares at $261.25 per share.
Den Broek Richard Van currently owns 20,000 shares of PhaseBio Pharmaceuticals Inc (PHAS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Den Broek Richard Van's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Den Broek Richard Van has 26 Form 4 filings on record as an insider at PhaseBio Pharmaceuticals Inc.
Set alerts for Den Broek Richard Van and 40,000+ other insiders.